Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Treatment of hypertension in rural Cambodia: results from a 6-year programme

Abstract

This study was aimed to describe the outcomes of a hypertension treatment programme in two outpatient clinics in Cambodia. We determined proportions of patients who met the optimal targets for blood pressure (BP) control and assessed the evolution of mean systolic and diastolic BP (SBP/DBP) over time. Multivariate analyses were used to identify predictors of BP decrease and risk factors for LTFU. A total of 2858 patients were enrolled between March 2002 and June 2008 of whom 69.2% were female, 30.5% were aged 64years and 32.6% were diabetic. The median follow-up time was 600 days. By the end of 2008, 1642 (57.4%) were alive-in-care, 8 (0.3%) had died and 1208 (42.3%) were lost to follow-up. On admission, mean SBP and DBP were 162 and 94 mm Hg, respectively. Among the patients treated, a significant SBP reduction of 26.8 mm Hg (95% CI: 28.4–25.3) was observed at 6 months. Overall, 36.5% of patients reached the BP targets at 24 months. The number of young adults, non-overweight patients and non-diabetics reaching the BP targets was more. Older age (>64 years), uncontrolled DBP (90 mm Hg) on last consultation and coming late for the last consultation were associated with LTFU, whereas non-diabetic patients were 1.5 times more likely to default than diabetics (95% CI: 1.3–1.7). Although the definite magnitude of the BP decrease due to antihypertension medication over time cannot be assessed definitely without a control group, our results suggest that BP reduction can be obtained with essential hypertension treatment in a large-scale programme in a resource-limited setting.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. WHO. Preventing chronic diseases: a vital investment: WHO global report. World Health Organization: Geneva, 2005.

  2. Suhrcke M, Nugent RA, Stuckler D, Rocco L . Chronic Diseases: an Economic Perspective. The Oxford Health Alliance: London, 2006.

    Google Scholar 

  3. Abegunde D, Mathers CD, Adam T, Ortegon M, Strong K . The burden and costs of chronic diseases in low-income and middle-income countries. Lancet 2007; 370: 1929–1938.

    Article  Google Scholar 

  4. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ . Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747–1757.

    Article  Google Scholar 

  5. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C et al. Major causes of death among men and women in China. N Engl J Med 2005; 353: 1124–1134.

    Article  CAS  Google Scholar 

  6. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1997; 277: 157–166.

    Article  Google Scholar 

  7. Hajjar I, Kotchen TA . Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003; 290: 199–206.

    Article  Google Scholar 

  8. Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B . Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992–1998. Hypertens Res 2004; 27: 703–709.

    Article  Google Scholar 

  9. Jafar TH, Levey AS, Jafary FH, White F, Gul A, Rahbar MH et al. Ethnic subgroup differences in hypertension in Pakistan. J Hypertens 2003; 21: 905–912.

    Article  CAS  Google Scholar 

  10. Pereira M, Lunet N, Azevedo A, Barros H . Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens 2009; 27: 963–975.

    Article  CAS  Google Scholar 

  11. King H, Lim K, Seng S, Khun T, Roglic G, Pinget M . Diabetes and associated disorders in Cambodia; two epidemiological surveys. Lancet 2005; 366: 1633–1639.

    Article  Google Scholar 

  12. Janssens B, Van Damme W, Raleigh B, Gupta J, Khem S, Soy Ty K et al. Offering integrated care for HIV/AIDS, diabetes and hypertension within chronic disease clinics in Cambodia. Bull World Health Organ 2007; 85 (11): 880–885.

    Article  CAS  Google Scholar 

  13. Raguenaud M-E, Isaakidis P, Reid T, Chy S, Keuky L, Arellano G et al. Treating 4000 diabetic patients in Cambodia, a high prevalence but resource-limited setting: a five-year study. BMC Med 2009; 7: 33.

    Article  Google Scholar 

  14. WHO Expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.

    Article  Google Scholar 

  15. Messerli FH, Williams B, Ritz E . Essential hypertension. Lancet 2007; 370 (9587): 591–603.

    Article  CAS  Google Scholar 

  16. Williams B . Recent hypertension trials: implications and controversies. J Am Coll Cardiol 2005; 45 (6): 813–827.

    Article  Google Scholar 

  17. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007; 28 (12): 1462–1536.

    Google Scholar 

  18. Mitka M . Research probes details of poor adherence in antihypertensive drug therapy. JAMA 2007; l298 (18): 2128.

    Google Scholar 

  19. Centers for Disease Control and Prevention (CDC). Racial/ethnic disparities in prevalence, treatment, and control of hypertension—United States, 1999–2002. MMWR Morb Mortal Wkly Rep 2005; 54 (1): 7–9.

    Google Scholar 

  20. Efstratopoulos AD, Voyaki SM, Baltas AA, Vratsistas FA, Kirlas DE, Kontoyannis JT et al. Prevalence, awareness, treatment and control of hypertension in Hellas, Greece: the Hypertension Study in General Practice in Hellas (HYPERTENSHELL) national study. Am J Hypertens 2006; 19 (1): 53–60.

    Article  Google Scholar 

  21. Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A . Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study. Int J Epidemiol 2004; 33 (6): 1345–1352.

    Article  Google Scholar 

  22. Primatesta P, Brookes M, Poulter NR . Improved hypertension management and control: results from the health survey for England 1998. Hypertension 2001; 38 (4): 827–832.

    Article  CAS  Google Scholar 

  23. Primatesta P, Poulter NR . Improvement in hypertension management in England: results from the health survey for England 2003. J Hypertens 2006; 24 (6): 1187–1192.

    Article  CAS  Google Scholar 

  24. Lang T, de Gaudemaris R, Chatellier G, Hamici L, Diène E . Prevalence and therapeutic control of hypertension in 30,000 subjects in the workplace. Hypertension 2001; 38 (3): 449–454.

    Article  CAS  Google Scholar 

  25. Scheltens T, Bots ML, Numans ME, Grobbee DE, Hoes AW . Awareness, treatment and control of hypertension: the ‘rule of halves’ in an era of risk-based treatment of hypertension. J Hum Hypertens 2007; 21 (2): 99–106.

    Article  CAS  Google Scholar 

  26. Fasce E, Campos I, Ibáñez P, Flores M, Zárate H, Román O et al. Trends in prevalence, awareness, treatment and control of hypertension in urban communities in Chile. J Hypertens 2007; 25 (9): 1807–1811.

    Article  CAS  Google Scholar 

  27. Wang Z, Wu Y, Zhao L, Li Y, Yang J, Zhou B . Trends in prevalence, awareness, treatment and control of hypertension in the middle-aged population of China, 1992–1998. Hypertens Res 2004; 27 (10): 703–709.

    Article  Google Scholar 

  28. Li W, Jiang X, Ma H, Yu TS, Ma L, Puente JG et al. Awareness, treatment and control of hypertension in patients attending hospital clinics in China. J Hypertens 2003; 21 (6): 1191–1197.

    Article  Google Scholar 

  29. Howteerakul N, Suwannapong N, Sittilerd R, Rawdaree P . Health risk behaviours, awareness, treatment and control of hypertension among rural community people in Thailand. Asia Pac J Public Health 2006; 18 (1): 3–9. Links.

    Article  CAS  Google Scholar 

  30. Hazarika NC, Narain K, Biswas D, Kalita HC, Mahanta J . Hypertension in the native rural population of Assam. Natl Med J India 2004; 17 (6): 300–304.

    CAS  Google Scholar 

  31. Lim TO, Morad Z . Prevalence, awareness, treatment and control of hypertension in the Malaysian adult population: results from the national health and morbidity survey 1996. Singapore Med J 2004; 45 (1): 20–27.

    CAS  PubMed  Google Scholar 

  32. Addo J, Smeeth L, Leon DA . Hypertension in sub-Saharan Africa: a systematic review. Hypertension 2007; 50 (6): 1012–1018.

    Article  CAS  Google Scholar 

  33. Isaakidis P, Swingler GH, Pienaar E, Volmink J, Ioannidis JP . Relation between burden of disease and randomised evidence in sub-Saharan Africa: survey of research. BMJ 2002; 324 (7339): 702.

    Article  Google Scholar 

  34. Stockwell DH, Madhavan S, Cohen H, Gibson G, Alderman MH . The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health 1994; 84 (11): 1768–1774.

    Article  CAS  Google Scholar 

  35. Alexander M, Tekawa I, Hunkeler E, Fireman B, Rowell R, Selby JV et al. Evaluating hypertension control in a managed care setting. Arch Intern Med 1999; 159: 2673–2677.

    Article  CAS  Google Scholar 

  36. Knight EL, Bohn RL, Wang PS, Glynn RJ, Mogun H, Avorn J . Predictors of uncontrolled hypertension in ambulatory patients. Hypertension 2001; 38 (4): 809–814.

    Article  CAS  Google Scholar 

  37. Hicks LS, Fairchild DG, Horng MS, Orav EJ, Bates DW, Ayanian JZ . Determinants of JNC VI guideline adherence, intensity of drug therapy, and blood pressure control by race and ethnicity. Hypertension 2004; 44 (4): 429–434.

    Article  CAS  Google Scholar 

  38. Majernick TG, Zacker C, Madden NA, Belletti DA, Arcona S . Correlates of hypertension control in a primary care setting. Am J Hypertens 2004; 17 (10): 915–920.

    Article  Google Scholar 

  39. Bovet P, Burnier M, Madeleine G, Waeber B, Paccaud F . Monitoring one-year compliance to antihypertension medication in the Seychelles. Bull World Health Organ 2002; 80 (1): 33–39.

    PubMed  PubMed Central  Google Scholar 

  40. Chean Rithy Men. Qualitative study on health care access among HIV/AIDS and diabetic patients in Cambodia. Research project supported by the European Commission. 2007 (EuropeAID, Health/2002/045-809).

  41. Binagwaho A, Ratnayake N . The role of social capital in successful adherence to antiretroviral therapy in Africa. PLoS Med 2009; 6 (1): e18.

    Article  Google Scholar 

  42. Bovet P, Gervasoni JP, Ross AG, Mkamba M, Mtasiwa DM, Lengeler C et al. Assessing the prevalence of hypertension in populations: are we doing it right? J Hypertens 2003; 21 (3): 473–474.

    Article  Google Scholar 

Download references

Acknowledgements

We acknowledge Sopheap Khem who developed the chronic diseases software and ensured the quality of the database, and Dr Kruy Lim from Center of Hope (Phnom Penh) for clinical advice. Funding source: Médecins Sans Frontières private funds.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P Isaakidis.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Isaakidis, P., Raguenaud, ME., Say, C. et al. Treatment of hypertension in rural Cambodia: results from a 6-year programme. J Hum Hypertens 25, 241–249 (2011). https://doi.org/10.1038/jhh.2010.49

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2010.49

Keywords

This article is cited by

Search

Quick links